Marie leads Lilly’s development efforts for Diabetes Connected Care and insulins. In her role, Marie is responsible for setting the development strategy for a portfolio that includes molecules, delivery and sensing devices, and digital decision support..
Prior to joining Lilly in 2015, Marie served as principal of Schiller Advisors. From 1998-2014, she held a number of roles at Health Advances, including Managing Director and Partner. During this time, Marie also co-founded the T1D Exchange, a novel data collection and clinical trial platform funded by the Helmsley Charitable Trust.
Marie earned her Bachelor of Arts in chemistry from the University of Vermont. Marie brings more than 25 years
of experience leading teams to develop breakthrough products for people living with chronic diseases. On a
personal note, Marie’s career has in part been motivated by her personal 37-year history with type 1 diabetes.